Healthcare & Life Sciences
Brenig Therapeutics
Israelwww.brenigther.com/
Brenig Therapeutics is a Healthcare & Life Sciences startup based in Israel, most recent round Series A, 2 tracked investors.
activeseries-a
series-a
Stage
2021
Founded
2
Investors
About Brenig Therapeutics
Brenig Therapeutics is a company founded in 2021 headquartered in Israel. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Brenig Therapeutics develops highly selective small-molecule therapies targeting neurodegenerative diseases, with a focus on Parkinson's disease through brain-penetrant inhibitors of LRRK2 and NLRP3 inflammasome pathways.
Explore Brenig Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.